Catch up on the latest

adjumax

Press Release

Successful Conclusion of Groundbreaking First-in-Human Trial for Revolutionary Non-Blood-Contacting reBEAT Heart Support Device, Clears Path for Transformative US study (2025)

August 2025

Publications

First-in-Human Experience With a Biventricular, Pulsatile MCS Platform Technology Avoiding Blood Contact: Translational Insights, JACC: Basic to Translational Science (2025)

February 2025

Biventricular assistance for patients with advanced heart failure

Disclaimer: reBEAT is a biventricular cardiac support device that avoids blood contact, which is currently exclusively used in clinical investigations and not yet available for sale.

ADJUCOR GMBH

18 Neumarkter Street
81673 Munich
Germany

info@adjucor.com
+49 89 262-049-600

Managing Director
Professor Dr. med. Stephen Wildhirt
HRB: 183620
U-ID: DE 271301817

Web Design & Development by Kri8it Digital